NDC codes

FDA NDC Directory
Product NDC (as listed)50090-7979Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50090-7979Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50090-7979-05009079790030 TABLET in 1 BOTTLE (50090-7979-0)Marketed from May 27, 2026
50090-7979-15009079790190 TABLET in 1 BOTTLE (50090-7979-1)Marketed from May 27, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Olmesartan Medoxomil
Generic name (nonproprietary)
olmesartan medoxomil
Active ingredients
Olmesartan medoxomil40 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 206720
Marketing start
Listing expires
Other FDA classes
Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers
Product ID 50090-7979_4fce0ea5-232e-4894-a2ee-3c9bb28149b0SPL ID 4fce0ea5-232e-4894-a2ee-3c9bb28149b0SPL set ID 4bf142a3-ad7f-4ed5-98c2-54d8509b7dbcRxCUI 349405UNII 6M97XTV3HD

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090797900 followed by a unit qualifier and the quantity

Package 50090-7979-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil is indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes m

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206720

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206720
ProductStrengthForm · routeLabelerProduct NDC
Olmesartan MedoxomilOlmesartan medoxomil 20 mg/1TabletOralBryant Ranch Prepack71335-2399
Olmesartan MedoxomilOlmesartan medoxomil 40 mg/1TabletOralA-S Medication Solutions50090-7980
Olmesartan MedoxomilOlmesartan medoxomil 40 mg/1TabletOralSolco Healthcare US, LLC.43547-301
Olmesartan MedoxomilOlmesartan medoxomil 5 mg/1TabletOralSolco Healthcare US, LLC.43547-299
Olmesartan MedoxomilOlmesartan medoxomil 20 mg/1TabletOralSolco Healthcare US, LLC.43547-300
Olmesartan MedoxomilOlmesartan medoxomil 20 mg/1TabletOralDirect_rx72189-558
Olmesartan MedoxomilOlmesartan medoxomil 40 mg/1TabletOralBryant Ranch Prepack71335-2605

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in